Statistics for Scpharmaceuticals (id:8093 SCPH)

Valuation metrics

Market cap

173.14M

Enterprise value

166.59M

Trailing P/E (ttm)

-2.36

Forward P/E

-4.74

PEG ratio

-4.74

Price/Sales (ttm)

5.72

Price/Book (mrq)

3.34

Enterprise Value/Revenue

12.26

Enterprise Value/EBITDA

-3.62

Overview

Shares outstanding

50.04M

Float

21.22M

Shares short

4.13M

% Held by insiders

0.08%

% Held by institutions

0.75%

Average volume (10 days)

819.48K

Average volume (90 days)

Price summary

52-Week low

3.08

52-Week high

6.71

52-Week change

-64.18%

Beta

0.14

50-Day moving average

4.36

200-Day moving average

4.69

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-264.60%

Operating margin

-180.99%

Operational effectiveness

Return on assets

-58.01%

Return on equity

-147.27%

Income statement

Revenue (ttm)

0.74

Revenue per share (ttm)

0.74

Quarterly revenue growth (yoy)

Gross profit (ttm)

9.78M

EBITDA

-63,669,000.00

Net income to common (ttm)

-80,115,000.00

Diluted EPS (ttm)

-1.95

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

0.00

Total cash per share (mrq)

0.78

Total debt (mrq)

52.50M

Total Debt/Equity (mrq)

447.18

Current ratio (mrq)

807.97%

Book value per share (mrq)

1.04

Cash flow

Cash flow statement

-53,704,000.00

Levered free cash flow (LFCF)

-99,965,000.00